ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.

March 5, 2004

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

Women’s Caucus Calls For Wide Mammogram Payment

March 18, 1994

Cancer Caused By Environmental Exposure “Grossly Underestimated,” Cancer Panel Says.

May 7, 2010

In Brief: Waxman Now Key House Health Figure; Kennedy Subcommittee Beefed Up with Top Democrats

February 9, 1979

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990